feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

trending

Islamabad suicide blast kills 31

trending

Ronaldo trains with Al Nassr

trending

India A vs Namibia live

trending

Vaibhav Suryavanshi scores 175

trending

VTU adopts Artificial Super Intelligence

trending

Riyan Parag scores fifty

trending

T20 World Cup opening ceremony

trending

Tiigers Kolkata reach ISPL final

trending

Al Ettifaq favored vs Damac

Home / Science / Alzheimer's Breakthrough: New Study Targets Blood Flow

Alzheimer's Breakthrough: New Study Targets Blood Flow

7 Feb

•

Summary

  • Researchers activated a protein to improve brain blood flow in Alzheimer's mice.
  • Improved blood flow is crucial for combating early Alzheimer's symptoms.
  • This study offers hope for new Alzheimer's therapeutic strategies.
Alzheimer's Breakthrough: New Study Targets Blood Flow

University of Miami researchers have made a significant stride in Alzheimer's treatment by successfully improving cerebrovascular function in a mouse model of the disease. Published in December 2025, the study focused on activating Piezo1, a protein found in blood vessels. This activation led to improved microvascular flow and neurovascular coupling, addressing early features of Alzheimer's that contribute to its progression.

The research team, comprising Ph.D. students Supriya Chakraborty and Zeynad Tabrizi, utilized pharmacological methods to enhance functional hyperemia, a vital increase in blood flow to the brain and muscles. Their findings suggest this approach holds substantial promise as a therapeutic strategy for humans suffering from Alzheimer's.

Chakraborty's path to neurodegenerative research was inspired by immunology, while Tabrizi brought her prior experience in neuroscience and immunology from Iran to the project. Both researchers emphasized the profound impact their work could have, not only for patients but also for their families and caregivers, aiming to aid in battling the disease on multiple fronts.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Researchers activated the Piezo1 protein, a mechanosensitive ion channel functionally expressed in blood vessels.
Reduced blood flow and impaired vascular responses in the brain are early features of Alzheimer's that contribute to the disease's progression.
This research offers a promising new therapeutic strategy for humans, potentially leading to more effective treatments or even a cure for Alzheimer's disease.

Read more news on

Scienceside-arrow

You may also like

THC Combo Fights Alzheimer's: New Hope

5 Feb • 6 reads

article image

Severe CTE Linked to Dementia Risk

28 Jan • 55 reads

article image

Mini Brains Get Blood Flow Boost

30 Dec, 2025 • 209 reads

article image

Early Dementia Diagnosis: A Postcard's Path

17 Dec, 2025 • 229 reads

Driving Habits Hint at Early Brain Decline

4 Dec, 2025 • 238 reads

article image